Literature DB >> 15364925

Antigen stability controls antigen presentation.

Robert Thai1, Gervaise Moine, Michel Desmadril, Denis Servent, Jean-Luc Tarride, André Ménez, Michel Léonetti.   

Abstract

We investigated whether protein stability controls antigen presentation using a four disulfide-containing snake toxin and three derivatives carrying one or two mutations (L1A, L1A/H4Y, and H4Y). These mutations were anticipated to increase (H4Y) or decrease (L1A) the antigen non-covalent stabilizing interactions, H4Y being naturally and frequently observed in neurotoxins. The chemically synthesized derivatives shared similar three-dimensional structure, biological activity, and T epitope pattern. However, they displayed differential thermal unfolding capacities, ranging from 65 to 98 degrees C. Using these differentially stable derivatives, we demonstrated that antigen stability controls antigen proteolysis, antigen processing in antigen-presenting cells, T cell stimulation, and kinetics of expression of T cell determinants. Therefore, non-covalent interactions that control the unfolding capacity of an antigen are key parameters in the efficacy of antigen presentation. By affecting the stabilizing interaction network of proteins, some natural mutations may modulate the subsequent T-cell stimulation and might help microorganisms to escape the immune response.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15364925     DOI: 10.1074/jbc.M405738200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Influence of aggregation on immunogenicity of recombinant human Factor VIII in hemophilia A mice.

Authors:  Vivek S Purohit; C Russell Middaugh; Sathyamangalam V Balasubramanian
Journal:  J Pharm Sci       Date:  2006-02       Impact factor: 3.534

2.  T-cell responses to the trypanosome variant surface glycoprotein are not limited to hypervariable subregions.

Authors:  Taylor R Dagenais; Karen P Demick; James D Bangs; Katrina T Forest; Donna M Paulnock; John M Mansfield
Journal:  Infect Immun       Date:  2008-10-20       Impact factor: 3.441

3.  Influence of high hydrostatic pressure on epitope mapping of tobacco mosaic virus coat protein.

Authors:  Daniel Ferreira de Lima Neto; Carlos Francisco Sampaio Bonafe; Clarice Weis Arns
Journal:  Viral Immunol       Date:  2014-03       Impact factor: 2.257

4.  Conformational instability governed by disulfide bonds partitions the dominant from subdominant helper T-cell responses specific for HIV-1 envelope glycoprotein gp120.

Authors:  Hong-Nam P Nguyen; N Kalaya Steede; James E Robinson; Samuel J Landry
Journal:  Vaccine       Date:  2015-05-02       Impact factor: 3.641

5.  Anthrax sub-unit vaccine: the structural consequences of binding rPA83 to Alhydrogel®.

Authors:  Andrei Soliakov; Ian F Kelly; Jeremy H Lakey; Allan Watkinson
Journal:  Eur J Pharm Biopharm       Date:  2011-09-22       Impact factor: 5.571

6.  Molecular cloning and expression analysis of the interferon-γ-inducible lysosomal thiol reductase gene from the shrimp Penaeus monodon.

Authors:  Kittima Kongton; Amornrat Phongdara; Moltira Tonganunt-Srithaworn; Warapond Wanna
Journal:  Mol Biol Rep       Date:  2010-11-26       Impact factor: 2.316

7.  Hemocyanins Stimulate Innate Immunity by Inducing Different Temporal Patterns of Proinflammatory Cytokine Expression in Macrophages.

Authors:  Ta-Ying Zhong; Sergio Arancibia; Raimundo Born; Ricardo Tampe; Javiera Villar; Miguel Del Campo; Augusto Manubens; María Inés Becker
Journal:  J Immunol       Date:  2016-04-22       Impact factor: 5.422

8.  Influence of protein conformation and adjuvant aggregation on the effectiveness of aluminum hydroxide adjuvant in a model alkaline phosphatase vaccine.

Authors:  Amber L Clausi; Andrea Morin; John F Carpenter; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2009-01       Impact factor: 3.534

9.  The pharmacological chaperone AT2220 increases recombinant human acid α-glucosidase uptake and glycogen reduction in a mouse model of Pompe disease.

Authors:  Richie Khanna; John J Flanagan; Jessie Feng; Rebecca Soska; Michelle Frascella; Lee J Pellegrino; Yi Lun; Darlene Guillen; David J Lockhart; Kenneth J Valenzano
Journal:  PLoS One       Date:  2012-07-18       Impact factor: 3.240

10.  Improved drug-like properties of therapeutic proteins by directed evolution.

Authors:  Andrew Buchanan; Franco Ferraro; Steven Rust; Sudharsan Sridharan; Ruth Franks; Greg Dean; Matthew McCourt; Lutz Jermutus; Ralph Minter
Journal:  Protein Eng Des Sel       Date:  2012-08-31       Impact factor: 1.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.